Alpharma Inc. (NYSE: ALO) has been notified by the FDA that its pending application for KADIAN 80mg ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE